As a preclinical CRO focused on Efficacy studies, at Syncrosome we decided that the first point is the quality of scientific discussions with sponsors, and our ability to fully understand your scientific goals. The second point is to provide you with robust data, and up-to-date techniques.
We are organized for that.
This combination of scientific aspects, high content data, relevant disease models, good procedures and high level of interpretation of results is the key point of our approach.
Holder of a PhD in Neurosciences, she has 15 years of experience in academic research and private companies.
Sandra is specialized in non clinical pharmacology, physiopathology and disease modeling. She joined SYNCROSOME in 2005 and she is now in charge of the Scientific Coordination of the studies.
She has also been scientific consultant for other companies.
Holder of a MSc in Biology, Caroline started has an in vivo technician in 2005. She acquired a lot of expertize in surgery, technical acts with rodents and non-rodents species during her career at Sanofi, Biocodex and Syncrosome.
She joined Syncrosome in 2008.
She also acquired in vitro skills during her professional background and is in charge of Syncrosome Laboratory activities.
SYNCROSOME scientific team includes PhDs, technicians, biologists, veterinarian and works with a network of preferred partners to offer a high scientific level of expertise in developing disease models at the preclinical stage to anticipate clinical endpoints after the first in vitro screening of its customers.
We have a large experiencewith different departments of Major, Midsized Pharma’s and small biotech companies, since 2000.
SYNCROSOME customer relation and scientific teams are available, before or after your study started, to answer your questions. The support team’s responsiveness and desire to meet and exceed customer expectations ensure that it can respond to specific and individual projects swiftly.